Bausch Health Companies (BHC) Tax Provisions (2009 - 2026)
Bausch Health Companies (BHC) posted Tax Provisions of $88.0 million for Q2 2026, up 14.29% sequentially from $77.0 million in Q1 2026, and up 633.33% YoY from $12.0 million in Q2 2025.
Bausch Health Companies (BHC) Tax Provisions (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Tax Provisions for 18 years, with the latest figure at $88.0 million in Q2 2026.
- Quarterly Tax Provisions rose 633.33% year-over-year to $88.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $361.0 million (up 54.94% YoY) and the FY2025 annual result came in at $247.0 million, up 3.35% from the prior year.
- Tax Provisions climbed to $88.0 million in Q2 2026 per BHC's latest filing, from $77.0 million in the prior quarter.
- Over five years, Tax Provisions peaked at $159.0 million in Q4 2025 and troughed at -$16.0 million in Q1 2022.
- A 5-year average of $53.1 million and a median of $50.5 million in 2023 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2022 and 2026: Tax Provisions plunged 200.0% in 2022, then jumped 633.33% in 2026.
- Over 5 years, Tax Provisions stood at $53.0 million in 2022, then retreated by 24.53% to $40.0 million in 2023, then soared by 177.5% to $111.0 million in 2024, then soared by 43.24% to $159.0 million in 2025, then sank by 44.65% to $88.0 million in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $88.0 million, $77.0 million, and $159.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Bausch Health Companies | 2.58 Bn | 738.25 Mn | 2.10 Bn | 88.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 88.00 Mn |
| Mar 31, 2026 | 77.00 Mn |
| Dec 31, 2025 | 159.00 Mn |
| Sep 30, 2025 | 37.00 Mn |
| Jun 30, 2025 | 12.00 Mn |
| Mar 31, 2025 | 39.00 Mn |
| Dec 31, 2024 | 111.00 Mn |
| Sep 30, 2024 | 71.00 Mn |
| Jun 30, 2024 | 49.00 Mn |
| Mar 31, 2024 | 8.00 Mn |
| Dec 31, 2023 | 40.00 Mn |
| Sep 30, 2023 | 56.00 Mn |
| Jun 30, 2023 | 52.00 Mn |
| Mar 31, 2023 | 73.00 Mn |
| Dec 31, 2022 | 53.00 Mn |
| Sep 30, 2022 | 36.00 Mn |
| Jun 30, 2022 | 10.00 Mn |
| Mar 31, 2022 | -16.00 Mn |
| Dec 31, 2021 | -51.00 Mn |
| Sep 30, 2021 | 25.00 Mn |